ATE412666T1 - Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität - Google Patents

Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität

Info

Publication number: ATE412666T1
Authority: AT; Austria
Prior art keywords: motif; rsv; immunity; compositions; methods
Prior art date: 2000-10-18

Application number

AT01987765T

Other languages

English (en)

Inventor

Ralph Tripp

Les Jones

Larry Anderson

Original Assignee

Us Gov Health & Human Serv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-18

Filing date

2001-10-18

Publication date

2008-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22911027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE412666(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-10-18 Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv

2008-11-15 Application granted granted Critical

2008-11-15 Publication of ATE412666T1 publication Critical patent/ATE412666T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT01987765T 2000-10-18 2001-10-18 Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität ATE412666T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US24152100P	2000-10-18	2000-10-18

Publications (1)

Publication Number	Publication Date
ATE412666T1 true ATE412666T1 (de)	2008-11-15

Family

ID=22911027

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01987765T ATE412666T1 (de)	2000-10-18	2001-10-18	Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität

Country Status (9)

Country	Link
US (4)	US20040009177A1 (de)
EP (1)	EP1334119B2 (de)
AT (1)	ATE412666T1 (de)
AU (2)	AU2002224416A1 (de)
CA (1)	CA2426312C (de)
DE (1)	DE60136381D1 (de)
DK (1)	DK1334119T4 (de)
ES (1)	ES2316487T5 (de)
WO (1)	WO2002032942A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1768993A4 (de) *	2004-06-16	2008-07-23	Univ Johns Hopkins	Cysteinreiche region des humanen respiratorischen synzytial-virus und verwendungsverfahren dafür
CN101395182A (zh) *	2006-03-06	2009-03-25	西福根有限公司	用于治疗呼吸道合胞病毒感染的重组多克隆抗体
BRPI0808673A2 (pt) *	2007-03-06	2014-08-12	Symphogen As	Anticorpos recombinantes para tratamento de infecções com vírus sinciciais respiratórios.
BRPI0819210A2 (pt) *	2007-10-25	2015-06-23	Trellis Bioscience Inc	Anticorpos de proteína g anti-rsv
GB0724253D0 (en) *	2007-12-12	2008-01-30	Fermentas Uab	Transfection reagent
WO2009128949A2 (en) *	2008-04-18	2009-10-22	Vaxinnate Corporation	Compositions of dengue viral proteins and methods of use
US20110318376A1 (en) *	2008-12-24	2011-12-29	University Of Rochester	Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins
WO2011017442A2 (en)	2009-08-04	2011-02-10	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention	Anti-rsv immunogens and methods of immunization
US9856456B2 (en)	2009-10-12	2018-01-02	Thermo Fisher Scientific Baltics Uab	Delivery agent
GB0917792D0 (en) *	2009-10-12	2009-11-25	Fermentas Uab	Delivery agent
CA2799934C (en)	2010-07-07	2020-01-28	Artificial Cell Technologies, Inc.	Respiratory syncytial virus antigenic compositions and methods
US10283774B2 (en) *	2010-07-28	2019-05-07	Nissan Motor Co., Ltd.	Bipolar electrode, bipolar secondary battery using the same and method for manufacturing bipolar electrode
KR102264852B1 (ko)	2012-08-01	2021-06-14	버베리안 노딕 에이/에스	재조합 변형된 백시니아 바이러스 앙카라(ankara) (mva) 호흡기 신시티알 바이러스(rsv) 백신
EP2993009A1 (de) *	2014-09-08	2016-03-09	HILTI Aktiengesellschaft	Verfahren zur Steuerung eines Wandsägesystems beim Erstellen eines Trennschnittes
SE539731C2 (sv)	2016-03-04	2017-11-14	Vertical Wind Ab	Rotor för en elektrisk generator och förfarande för dess tillverkning
EP3694548A4 (de) *	2017-10-13	2021-10-20	Trellis Bioscience, LLC	Konformationelle epitope in der zentralen konservierten region des g-proteins des respiratorischen synzytial-virus
US11201095B1 (en)	2019-08-23	2021-12-14	Xilinx, Inc.	Chip package having a cover with window
EP4125936A4 (de) *	2020-03-23	2024-03-27	Atossa Therapeutics, Inc.	Heparin und n-acetylcystein zur behandlung eines respiratorischen virus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2718452B1 (fr)	1994-04-06	1996-06-28	Pf Medicament	Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
CA2198279A1 (en)	1994-08-25	1996-02-29	Johannes Petrus Maria Langedijk	Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection
ATE389018T1 (de) †	1996-01-24	2008-03-15	Schering Corp	Cx3c chemokin-gene von säugetieren
AUPO026596A0 (en)	1996-06-05	1996-06-27	Biomolecular Research Institute Limited	Viral peptide
US6020182A (en) *	1996-07-12	2000-02-01	Connaught Laboratories Limited	Subunit respiratory syncytial virus vaccine preparation
EP1010692A1 (de)	1997-07-04	2000-06-21	Chisso Corporation	Flüssigkristalline verbindungen mit hoher anisotroper durchlässigkeit, flüssigkristalline zusammensetzung die diese verbindungen enthält und flüssigkristallines anzeigeelement, das unter verwendung der flüssigkristallinen zusammensetzung hergestellt wurde
AU751022B2 (en) *	1997-09-19	2002-08-08	Wyeth Holdings Corporation	Peptides derived from the attachment (G) protein of respiratory syncytial virus
FR2827605B1 (fr)	2001-07-20	2004-07-16	Pf Medicament	Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin

2001
- 2001-10-18 EP EP01987765.3A patent/EP1334119B2/de not_active Expired - Lifetime
- 2001-10-18 WO PCT/US2001/032459 patent/WO2002032942A2/en active Search and Examination
- 2001-10-18 DK DK01987765.3T patent/DK1334119T4/en active
- 2001-10-18 CA CA2426312A patent/CA2426312C/en not_active Expired - Lifetime
- 2001-10-18 AU AU2002224416A patent/AU2002224416A1/en not_active Abandoned
- 2001-10-18 DE DE60136381T patent/DE60136381D1/de not_active Expired - Lifetime
- 2001-10-18 ES ES01987765T patent/ES2316487T5/es not_active Expired - Lifetime
- 2001-10-18 AT AT01987765T patent/ATE412666T1/de not_active IP Right Cessation
2003
- 2003-04-18 US US10/420,387 patent/US20040009177A1/en not_active Abandoned
2005
- 2005-05-26 US US11/139,372 patent/US8173131B2/en not_active Expired - Fee Related
2009
- 2009-03-12 AU AU2009200997A patent/AU2009200997B2/en not_active Expired
2012
- 2012-01-25 US US13/358,320 patent/US8778354B2/en not_active Expired - Fee Related
2014
- 2014-04-15 US US14/252,836 patent/US20140288267A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2009200997A1 (en)	2009-04-02
US8173131B2 (en)	2012-05-08
US20060018925A1 (en)	2006-01-26
WO2002032942A2 (en)	2002-04-25
DK1334119T4 (en)	2019-03-18
US20140288267A1 (en)	2014-09-25
EP1334119B2 (de)	2018-11-28
DE60136381D1 (de)	2008-12-11
US20120258111A1 (en)	2012-10-11
CA2426312A1 (en)	2002-04-25
AU2009200997B2 (en)	2011-12-22
EP1334119B1 (de)	2008-10-29
CA2426312C (en)	2014-01-14
AU2002224416A1 (en)	2002-04-29
ES2316487T5 (es)	2019-05-13
ES2316487T3 (es)	2009-04-16
EP1334119A2 (de)	2003-08-13
WO2002032942A3 (en)	2002-12-12
US8778354B2 (en)	2014-07-15
DK1334119T3 (da)	2009-02-23
US20040009177A1 (en)	2004-01-15

Publication	Publication Date	Title
DE60136381D1 (de)	2008-12-11	Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität
MY138860A (en)	2009-08-28	Hiv protease inhibitors.
ATE475423T1 (de)	2010-08-15	Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen
ATE327246T1 (de)	2006-06-15	Hepatitis c tripeptid inhibitoren
EP1362127A4 (de)	2004-09-22	Serpin-arzneistoffe zur behandlung einer hiv-infektion und verfahren zu deren verwendung
ATE310089T1 (de)	2005-12-15	Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
IS7533A (is)	2004-11-16	Lifrarbólgu C-veirutálmar
ATE497775T1 (de)	2011-02-15	Verwendung einer kombination von cyclosporin und pegylierten interferonen zur behandlung von hepatitis c (hcv)
DK1479691T3 (da)	2007-03-12	Langvarigt aktive fuionspeptidinhibitorer for HIV infektion
MA27699A1 (fr)	2006-01-02	Vaccin contre vhc
DE60137146D1 (de)	2009-02-05	Fusionszellen und zytokin-zusammensetzungen zur behandlung von krankheiten
AR005750A1 (es)	1999-07-14	Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion
WO2006109174A3 (en)	2008-01-03	Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid
ATE486088T1 (de)	2010-11-15	Hiv-impfstoff
DE60104815D1 (de)	2004-09-16	Bakteriophagen-assoziierte lytische enzyme zur therapeutischen behandlung von bakteriellen infektionen
UA41338C2 (uk)	2001-09-17	Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
DE69932741D1 (de)	2006-09-21	Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
ATE411812T1 (de)	2008-11-15	Peptide zur behandlung von infektionen mit dem herpes-virus
ATE408421T1 (de)	2008-10-15	Pna-konjugat zur therapie von mit hiv in zusammenhang stehenden erkrankungen
ATE237616T1 (de)	2003-05-15	Verwendung von (1r,4s)-4-(6-amino-9h-purin-9-yl)- 2-cyclopenten-1-methanol in hbv
ATE121935T1 (de)	1995-05-15	D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.
ATE212839T1 (de)	2002-02-15	Hämoregulatorische verbindungen
BR9708720A (pt)	2000-01-04	Composição farmacêutica e processo para o tratamento de demência por hiv.
JPS63198635A (ja)	1988-08-17	エイズ原因ウイルスに対する抗ウイルス剤
ATE266403T1 (de)	2004-05-15	Verwendung von 2-methyl-thiazolidin 2,4- dicarbonsäure zur herstellung eines medikaments zur behandlung von infektionskrankheiten

Legal Events

Date	Code	Title	Description
2009-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties